Aegean Conferences

5th International Conference on Cytokines in Cancer

Authors List

Important: The program online is copyrighted to each author and should not be copied and pasted!

Author	Abstracts
Afshar-Sterle Shoukat	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Amiet Nicole	*PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling*
Aplenc Anna	*Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
Aung* Myint	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Balestrero Federica	*Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression* *eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype*
Baloyan David	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Beauchamp Elspeth	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms* *Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity*
Behren Andreas	*Combination immunotherapy in patients with rare cancers*
Bekiaris Vasileios	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Benech Nicolas	*A new effector T cell subset leading to cancer*
Berger Walter	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Berindan-Neagoe Ioana	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment* *The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study* *Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer*
Bernardini Marcus	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Bianca Matthew	*Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma*
Bica Cecilia	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment* *The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study* *Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer*
Bielawska Anna	*The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells* *The anti-proliferative and anti-inflammatory effect of a novel 4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells*
Bielawski Krzysztof	*The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells* *The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells* *The anti-proliferative and anti-inflammatory effect of a novel 4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells*
Bonder Claudine	*Re-evaluating the tumour vasculature to improve cancer outcomes*
Borden Katherine	*Cancer cells subvert the RNA metabolism machinery to re-write the message and reprogramme the cell*
Braicu Cornelia	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment* *The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study* *Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer*
Britt Kara	*The role of the immune system in breast cancer risk and early tumour formation*
Brooks David	*Interferon-mediated regulation of T cell function and immunotherapy in cancer*
Buchert Michael	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Budisan Liviuta	*The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study*
Campbell Nicole	*Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells*
Carli Annalisa LE	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Chen Anna	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma*
Chira Sergiu	*The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study*
Chiroi Paul	*Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer*
Chisanga David	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Chung Douglas	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Ciccone Valerio	*Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression*
Ciocan Cristina	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment* *The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study* *Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer*
Ciudad Maria Teresa	*Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma*
Clarke Blaise	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Cohn Ronald	*STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice*
Colombo Giorgia	*Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype*
Condorelli Fabrizio	*eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype*
Consortium CONCORD-19	*IFN-ß ring prophylaxis to reduce SARS-CoV-2 transmission*
Crome Sarah	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Czarnomysy Robert	*The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells*
D'Amico Stephen	*STAT3 as a collateral dependency in KRAS mutant pancreatic cancer*
Darcy Phil	*PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling*
de Weerd Nicole	*Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells*
Dudchak Rostyslav	*The anti-proliferative and anti-inflammatory effect of a novel 4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells*
Eckerdt Frank	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms* *Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity*
Eissmann Moritz	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Elford Alisha	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Ernst Matthias	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development* *The gp130 signaling-cascade provides therapeutic vulnerabilities for solid malignancies*
Ferguson Sarah	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Fesneau Olivier	*A new effector T cell subset leading to cancer*
Fischietti Mariafausta	*Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity* *Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Fish Eleanor	*IFN-ß ring prophylaxis to reduce SARS-CoV-2 transmission* *Role of CHAF1B in interferon responses in myeloproliferative neoplasms* *Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity*
Freeman Andrew	*Unleashing TNF cytotoxicity to enhance cancer immunotherapy*
Garcia-Batres Carlos	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Gearing Linden	*Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells*
Gebhardt Thomas	*CD4 T cell immunity in cutaneous melanoma*
Genazzani Armando	*Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression* *Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype* *eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype*
Ghaedi Maryam	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Giordano Catello	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma* *Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
Gornowicz Agnieszka	*The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells* *The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells* *The anti-proliferative and anti-inflammatory effect of a novel 4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells*
Gotthardt Dagmar	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Gould Jodee	*Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells*
Grolla Ambra	*Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression* *eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype*
Guidos Cynthia	*STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice*
Haigh Jody	*JAK/BCL2 inhibition acts synergistically with LSD1 inhibitors to selectively target ETP-ALL.*
Halbritter Florian	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Han SeongJun	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Hao Fang	*STAT3 as a collateral dependency in KRAS mutant pancreatic cancer*
Harangus Antonia	*The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study*
Harari Daniel	*Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model* *Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model*
Herling Marco	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Hernandez-Vargas Hector	*A new effector T cell subset leading to cancer*
Herndler-Brandstetter Dietmar	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma*
Hertzog Paul	*Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells* *Interferon epsilon has tumour suppressor activities in ovarian cancer.*
Hoffman Ronald	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Hou Ye	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Isacescu Ecaterina	*Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer*
Ivakine Evgueni	*STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice*
Jablonska Jadwiga	*Immunoregulatory functions of neutrophils in cancer*
Jacquelot Nicolas	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Jin Robbie	*Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma*
Johnstone Ricky	*Unleashing TNF cytotoxicity to enhance cancer immunotherapy*
Kearney Conor	*Unleashing TNF cytotoxicity to enhance cancer immunotherapy*
Kenner Lukas	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma* *Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
Kirillov Varvara	*STAT3 as a collateral dependency in KRAS mutant pancreatic cancer*
Kosciuczuk Ewa	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Kraupp Sophie	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Leitner Judith	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma*
Lendzion Karolina	*The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells* *The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells*
Lesyk Roman	*The anti-proliferative and anti-inflammatory effect of a novel 4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells*
Liang Huang-Chang	*Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
List Julia	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Liu Zhe Qi	*Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma*
Locksley Richard M	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Look Thomas	*Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
Luo Yu Xuan	*Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells*
Marie Julien	*A new effector T cell subset leading to cancer*
Matthews Jessica	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
McGaha Tracy	*Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma*
Merkel Olaf	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma* *Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
Mishra Lopa	*Targeting NASH and HCC through intrinsically disordered proteins*
Möller Andreas	*Cytokines bound to cancer-derived extracellular vesicles impact immune cell phenotypes and metastasis*
Montaño-Gutierrez Luis	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Moriggl Richard	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Moro Marianna	*Exploring the role of eNAMPT (extracellular nicotinamide phosphoribosyltransferase) in tumoral progression* *eNAMPT-induced breast cancer cell reprogramming towards an invasive and metastatic phenotype*
Mueller Mathias	*PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling*
Neubauer Heidi	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Nguyen Linh	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Nutu Andreea	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment* *The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study*
O’Keefe Ryan N	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Ohashi Pamela	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Oliaro Jane	*Unleashing TNF cytotoxicity to enhance cancer immunotherapy*
Overall Christopher	Remodelling the interferon and chemokine activity landscape in COVID-19 and inflammatory responses by immune cell proteases and SARS-CoV-2 3Clpro main protease precision proteolysis reveals chinks in the cell's armour
Pal Bhupinder	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Parish Ian	*Restraint of early T cell activation by the tolerance checkpoint*
Parker Belinda	*Uncovering opportunities for immune targeting of bone metastases*
Perez Ricardo	*Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity* *Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Petrenko Oleksi	*STAT3 as a collateral dependency in KRAS mutant pancreatic cancer*
Pirker Christine	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Platanias Leonidas	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms* *Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity*
Podolak Magdalena	*The anti-proliferative and anti-inflammatory effect of a novel 4-thiazolidinone derivative in combination with anti-HER2 antibodies in human AGS gastric cancer cells*
Poh Ashleigh	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Pop Laura	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment* *Interconnection between miR-21, miR-181a, miR-155 and their target immune response genes: IL1, IL6, IL17, and TNFalpha in different subtypes of breast cancer*
Prutsch Nicole	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma* *Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
Putoczki Tracy	*Unravelling the contribution of TNF to pancreatic cancer*
Raduly Lajos	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment* *The role of the cytokines-related miRNAs in smoking female NSCLC; a comparative female versus male study*
Reich Marshall Nancy	*STAT3 as a collateral dependency in KRAS mutant pancreatic cancer*
Roifman Chaim	*STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice*
Rot Antal	*Accelerated experimental cancer growth and altered tumour-host interactions in mice with ACKR1-deficient erythroid cells*
Ruscetti Marcus	*Leveraging senescence-associated cytokine signaling for pancreatic cancer immunotherapy*
Saleiro Diana	*Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity* *Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Sangaletti Sabina	*Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype*
Sayad Azin	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Schönefeldt* Susann	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Schreiber Gideon	*Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model* *Localized type I interferon therapy improves immune infiltration and PD-blockade in a mouse melanoma model*
Scott Ori	*STAT1 gain-of-function DNA-binding-domain mutations cause immune dysregulation in humans and mice*
Seillet Cyril	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development*
Sek Kevin	*PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling*
Shaw Patricia	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Shi Wei	*A tuft cell - ILC2 signaling circuit provides therapeutic targets to inhibit gastric metaplasia and tumor development* *Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells*
Shilatifard Ali	*Principles of epigenetics and chromatin in development and human disease*
Silke John	*Unleashing TNF cytotoxicity to enhance cancer immunotherapy*
Singer Weinberg Rona	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Sorger Helena	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Spaner David	*Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells*
Steinberger Peter	*TYK2 inhibition causes not only apoptosis but also a marked anti-tumor immune response in Anaplastic Large Cell Lymphoma*
Suske Tobias	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Thevin Valentin	*A new effector T cell subset leading to cancer*
Tiganis Tony	*PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling* *PTPs and STATs in cancer immunotherapy*
Tomczyk Michal	*The effects of Scorzonera hispanica seeds on the cellular signaling pathways in MCF-7 breast cancer cells* *The influence of Scorzonera hispanica seeds on TNF-α and IL-8 concentrations in breast cancer cells*
Touaibia Mohamed	*Targeting core super-enhancer circuitries of anaplastic large cell lymphoma by rational design of IRF4 degrader drugs*
Travelli Cristina	*Extracellular Nicotinamide Phosphoribosyltransferase (eNAMPT) neutralization impairs TNBC burden, reducing cancer cell migration and T-cell suppressive phenotype*
Vakharia Jehan	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Vervoort Stephin	*Unleashing TNF cytotoxicity to enhance cancer immunotherapy*
Wagner Christina	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Wais Tamara	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Wan Yong	*Proteolytic regulation of CD73 by TRIM21 orchestrates tumor immunogenicity*
Wang Qixuan	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms* *CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes* *Enhanced IFN sensing by aggressive chronic lymphocytic leukemia cells*
Warner Kathrin	*CD103-expressing CD56+ regulatory ILCs suppresses intratumoural T cells and are associated with poor clinical outcomes*
Watowich Stephanie	*Association of the microbiome with response and toxicity to immune checkpoint inhibitors*
Wiede Florian	*PTP1B deficiency alleviates T cell exhaustion by promoting JAK/STAT signalling*
Wray-McCann Georgie	*Interferon epsilon limits ovarian cancer metastasis via regulation of peritoneal immune cells*
Yang G. Sohae	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Yue Feng	*Role of CHAF1B in interferon responses in myeloproliferative neoplasms*
Zahma Safia	*Investigating disease mechanisms and targetable dependencies in γδ T cell lymphoma using novel STAT5B-driven pre-clinical models*
Zannikou Markella	*Characterization of the SLFN5 Role in the Regulation of Immune Cells and Natural Killer (NK) Cells Anti-Tumor Activity*
Zanoaga Oana	*Cytokines profiling and their involvement in the ovarian adenocarcinoma tumour microenvironment*
Zhang Dong-Er	*USP18 in regulation of cancer immune responses* *Cancer cell SMAD4 mutations drive increased myeloid cell infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma*